SCHEMBL9593824

SCHEMBL9593824

CCC(C(=O)O)c1cc2cc(OC)ccc2o1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 4/20 0.62
▸ AKR1C2 P52895 4/20 0.62
▸ AKR1C1 Q04828 1/20 0.62
▸ PTGS1 P23219 1/20 0.62
▸ TAS1R3 Q7RTX0 6/20 0.56
▸ TAS1R1 Q7RTX1 6/20 0.56
▸ KDM4E B2RXH2 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA3 P07451 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ CA6 P23280 1/20 0.53
▸ CA5A P35218 1/20 0.53
▸ CA7 P43166 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ CA14 Q9ULX7 1/20 0.53
▸ CA5B Q9Y2D0 1/20 0.53
▸ MAOB P27338 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL505820 0.77 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1PTGS1KDM4E
SCHEMBL506301 0.77 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1PTGS1KDM4E
SCHEMBL32670173 0.77 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1PTGS1KDM4E
SCHEMBL3043390 0.77 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1PTGS1KDM4E
SCHEMBL32670176 0.77 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1PTGS1KDM4E
SCHEMBL24991971 0.77 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1PTGS1KDM4E
SCHEMBL9315720 0.76 AKR1C3 (0.46) AKR1C3AKR1C2TAS1R3TAS1R1KDM4E
SCHEMBL5507359 0.75 GPR55 (0.55) TAS1R3TAS1R1KDM4EALDH1A1CA12
SCHEMBL7922363 0.74 TAS1R3 (0.52) TAS1R3TAS1R1KDM4EALDH1A1CA12
SCHEMBL12301434 0.74 CYP2A6 (0.54) TAS1R3TAS1R1KDM4EALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 — — US disclosed
Send feedback